Explore all the latest information in myeloproliferative neoplasms, arranged by key congresses and meetings. Listed below are recently updated congresses and meetings.
What do we know about the outcome of concomitant MPN and COVID-19?
During the First Annual Texas Virtual MPN Workshop, the MPN Hub spoke to our Steering Committee members Laura Michaelis, Medical...
COVID-19: Implications for patients with myeloproliferative neoplasms
Summary of two presentations at the Texas Virtual MPN Workshop (TMW) 2020: First Annual Workshop and Meeting. The first from MPN...
How would you manage a young man with polycythemia vera and fatigue?
Interview with Gabriela Hobbs during the 2020 Annual Meeting of the SOHO. We asked the question: How would you manage a young man...
How can we predict and reduce the risk of thrombosis in a patient with PV?
Interview with Gabriela Hobbs during the 2020 Annual Meeting of the SOHO about reducing the risk of thrombosis in a patients...
Advances in allogeneic HSCT for patients with myelofibrosis
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only potentially curative treatment for patients with myelofibrosis...
The impact of JAK inhibitor use on HSCT outcome in patients with MPN
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potential curative option for patients with myeloproliferative...
The microbiome and its effects on the immune system
The MPN Hub was pleased to speak to Christine Spencer, Parker Institute for Cancer Immunotherapy, San Francisco, US, and Diwakar Davar, University...
How can we use the microbiome to improve cancer immunotherapy and alleviate side effects such as graft-versus-host-disease?
During the American Association of Cancer Research (AACR) Virtual Annual...
American Association of Cancer Research
American Society of Clinical Oncology
American Society of Hematology
European Hematology Association
European Society for Blood and Marrow Transplantation
Society of Hematologic Oncology
Texas MPN Workshop